Waterford, CT, United States of America

Michael J Morin


Average Co-Inventor Count = 9.0

ph-index = 2

Forward Citations = 60(Granted Patents)


Company Filing History:


Years Active: 2005-2006

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovative Mind of Michael J. Morin

Introduction: Michael J. Morin, an accomplished inventor based in Waterford, Connecticut, has made significant strides in the field of pharmaceuticals. With two patents to his name, he has contributed greatly to innovative treatments for abnormal cell growth, particularly in the context of cancer therapy.

Latest Patents: Morin's recent innovations include two notable patents. The first patent, titled "Treating abnormal cell growth with a stable polymorph of N-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)-4-quinazolinamine hydrochloride," outlines a method for effectively treating patients suffering from abnormal cell growth expressing the epidermal growth factor receptor (EGFR). This method comprises orally administering a therapeutically effective amount of a crystalline polymorph of the hydrochloride salt to patients. His second patent, “Stable polymorph on N-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)-4-quinazolinamine hydrochloride, methods of production, and pharmaceutical uses thereof,” describes a stable crystalline form designated as the B polymorph and its production in pure form. This invention has implications for treating hyperproliferative disorders, such as cancer, emphasizing the pharmaceutical compositions containing this stable polymorph.

Career Highlights: Michael J. Morin is currently employed at Osi Pharmaceuticals, Inc., where he plays an integral role in research and development. His work is at the forefront of innovative cancer therapies, showcasing his commitment to enhancing treatments for patients.

Collaborations: Throughout his career, Morin has collaborated with notable colleagues, including Timothy Norris and Jeffrey W. Raggon. These partnerships have fostered a collaborative environment that facilitates the advancement of their innovative research efforts.

Conclusion: Michael J. Morin exemplifies the spirit of innovation in the pharmaceutical industry. His contributions to the development of treatments for abnormal cell growth position him as a significant figure in the fight against cancer. With ongoing research and collaborations, Morin continues to impact the field positively, paving the way for future breakthroughs.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…